The availability of preclinical capacity and uncertainty created by mergers and healthcare reform have led to pharma exerting pricing pressure on Charles River, decreasing its sales by 13.1 per cent, and it expects the situation to worsen in Q4.
Contract research organisation PPD has boosted its compound partnering programme with the purchase of dermatology specialist Magen BioSciences, and divested its presclinical research subsidiary Pedmont Research Centre.
Nanogen and Fisher Scientific have announced an expansion to their
relationship to include a research and development collaboration in
molecular diagnostics. The collaboration agreement complements
Fisher's equity investment...
US-based contract research organisation The Smithers Group,
announced the acquisiton of UK company Rapra Technology in a deal
that seals the fate of Rapra, which was forced into Administration
Drug delivery specialists, Inyx has announced the acquisition of
Celltech Manufacturing Services from biopharmaceutical company UCB
for €27.5 million (€22.3 million). The acquisition adds to Inyx's
recently established operating...
German drug major Bayer has entered into a collaboration with
Artemis Pharmaceuticals focusing on the development of
genetically-engineered mice that are designed to have human-like
biology. The ArteMice will be used in Bayer's...
SC Biosciences is to be the exclusive distributor of sensitive
tools for drug discovery with the announcement this week that it
will distribute in vivo imaging technology in Japan for US company